Related Experiment Video
Updated: Aug 9, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
The other fungi: it's not just Candida albicans anymore
Alison R Saalwachter1, Traci Hedrick, Robert G Sawyer
1Department of Surgery, University of Virginia, Charlottesville, Virginia 22901, USA.
Background:
Candida albicans continues to be the fungus most often causing disease in surgical patients, but with the treatment of an increasing number of critically ill and immunosuppressed patients, other candidal and non-candidal fungal pathogens are becoming more common.
Methods:
Review of current practice and guidelines.
Results:
The presentation and management of non-C. albicans fungal infections differs depending on the genus and species. The availability of newer anti-fungal agents has in many cases improved outcomes or decreased toxicities associated with these diseases.
Conclusions:
Although such infections are still relatively uncommon, a working knowledge of infections with non-C. albicans fungi may be beneficial for surgeons, who are likely to encounter such patients both primarily and in consultation. Prompt recognition and treatment of these diseases should improve outcomes.
Insights
Non-Candida albicans fungal infections are increasing in critically ill patients. Understanding their unique presentation and management is crucial for surgeons to improve patient outcomes.
Area of Science:
- Medical Mycology
- Surgical Infectious Diseases
Background:
- Candida albicans is the most common fungal pathogen in surgical patients.
- Critically ill and immunosuppressed populations are experiencing an rise in non-C. albicans fungal infections.
- Emerging fungal pathogens pose a growing challenge in clinical settings.
Purpose of the Study:
- To review current practices and guidelines for managing non-C. albicans fungal infections.
- To highlight the differences in presentation and treatment compared to C. albicans.
- To emphasize the importance of recognizing and treating these infections promptly.
Main Methods:
- Literature review of current practices.
- Analysis of clinical guidelines.
Main Results:
- Non-C. albicans fungal infections present and are managed differently based on the specific pathogen.
- Newer antifungal agents offer improved efficacy and reduced toxicity for treating these infections.
- Early diagnosis and appropriate antifungal therapy are key to successful management.
Conclusions:
- While uncommon, non-C. albicans fungal infections require a working knowledge for surgeons.
- Prompt recognition and treatment of these infections can significantly improve patient outcomes.
- Fungal disease management in surgical patients necessitates awareness of a broader spectrum of pathogens beyond C. albicans.
Related Concept Videos
Candidiasis
Fungal Phylum Ascomycota
Fungal Group Zygomycota
Overview of Fungi
Fungal Phylum Basidiomycota
Fungal Phylum Microsporidia

